Journal of Hepatology
Volume 54, Issue 1 , Pages 56-63 , January 2011

Bleeding in patients with Budd–Chiari syndrome

  • Pierre-Emmanuel Rautou

      Affiliations

    • Pôle des Maladies de l’Appareil Digestif, Service d’Hépatologie, Hôpital Beaujon, AP-HP, Clichy, France
    • INSERM, U773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, Université Paris 7-Denis-Diderot, Clichy, France
    • These authors contributed equally to this work.
    • ,
  • Ludivine Douarin

      Affiliations

    • Pôle des Maladies de l’Appareil Digestif, Service d’Hépatologie, Hôpital Beaujon, AP-HP, Clichy, France
    • INSERM, U773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, Université Paris 7-Denis-Diderot, Clichy, France
    • These authors contributed equally to this work.
    • ,
  • Marie-Hélène Denninger

      Affiliations

    • Service d’Hématologie Biologique, Hôpital Beaujon, Clichy, France
    • ,
  • Sylvie Escolano

      Affiliations

    • INSERM U780, IFR69, 16 Avenue Paul Vaillant Couturier 94807 Villejuif, France
    • ,
  • Didier Lebrec

      Affiliations

    • Pôle des Maladies de l’Appareil Digestif, Service d’Hépatologie, Hôpital Beaujon, AP-HP, Clichy, France
    • INSERM, U773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, Université Paris 7-Denis-Diderot, Clichy, France
    • ,
  • Richard Moreau

      Affiliations

    • Pôle des Maladies de l’Appareil Digestif, Service d’Hépatologie, Hôpital Beaujon, AP-HP, Clichy, France
    • INSERM, U773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, Université Paris 7-Denis-Diderot, Clichy, France
    • ,
  • Michel Vidaud

      Affiliations

    • Laboratoire de Biochimie, Hôpital Beaujon, Clichy, France
    • ,
  • Raphaël Itzykson

      Affiliations

    • Service d’Hématologie Clinique, Hôpital Avicenne, AP-HP, Université Paris 13, Bobigny, France
    • ,
  • Rami Moucari

      Affiliations

    • Pôle des Maladies de l’Appareil Digestif, Service d’Hépatologie, Hôpital Beaujon, AP-HP, Clichy, France
    • INSERM, U773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, Université Paris 7-Denis-Diderot, Clichy, France
    • ,
  • Annie Bezeaud

      Affiliations

    • Service d’Hématologie Biologique, Hôpital Beaujon, Clichy, France
    • ,
  • Dominique Valla

      Affiliations

    • Pôle des Maladies de l’Appareil Digestif, Service d’Hépatologie, Hôpital Beaujon, AP-HP, Clichy, France
    • INSERM, U773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, Université Paris 7-Denis-Diderot, Clichy, France
    • Corresponding Author InformationCorresponding author at: Service d’Hépatologie and INSERM CRB3, Hôpital Beaujon, AP-HP, Clichy, France. Tel.: +33 1 40 87 55 94; fax: +33 1 40 87 44 26.
    • ,
  • Aurélie Plessier

      Affiliations

    • Pôle des Maladies de l’Appareil Digestif, Service d’Hépatologie, Hôpital Beaujon, AP-HP, Clichy, France
    • INSERM, U773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, Université Paris 7-Denis-Diderot, Clichy, France

Received 30 December 2009 ,Revised 10 May 2010 ,Accepted 8 June 2010.

References 

  1. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729–1764
  2. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, et al. Outcome of Budd–Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999;30:84–89
  3. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd–Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38:364–371
  4. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–176
  5. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006;55:878–884
  6. Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd–Chiari syndrome. Hepatology. 2006;44:1308–1316
  7. Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med. 2003;139:893–900
  8. Rautou PE, Moucari R, Cazals-Hatem D, Escolano S, Denie C, Douarin L, et al. Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd–Chiari syndrome. Clin Gastroenterol Hepatol. 2009;7:1230–1235
  9. Rautou PE, Moucari R, Escolano S, Cazals-Hatem D, Denie C, Chagneau-Derrode C, et al. Prognostic indices for Budd–Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol. 2009;104:1140–1146
  10. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:160S–198S
  11. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:454S–545S
  12. Garcia-Pagan JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, et al. TIPS for Budd–Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology. 2008;135:808–815
  13. Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O’Grady J, et al. Liver transplantation for Budd–Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol. 2006;44:520–528
  14. Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, et al. TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience. J Hepatol. 2003;38:751–754
  15. Kitchens CS, Weidner MH, Lottenberg R. Chronic oral anticoagulant therapy for extrahepatic visceral thrombosis is safe. J Thromb Thrombolysis. 2007;23:223–228
  16. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–938
  17. Gonzalez R, Zamora J, Gomez-Camarero J, Molinero LM, Banares R, Albillos A. Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med. 2008;149:109–122
  18. De Gottardi A, Thevenot T, Spahr L, Morard I, Bresson-Hadni S, Torres F, et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol. 2009;7:906–909
  19. Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd–Chiari syndrome. Hepatology. 2004;39:500–508

PII: S0168-8278(10)00709-9

doi: 10.1016/j.jhep.2010.06.019

Journal of Hepatology
Volume 54, Issue 1 , Pages 56-63 , January 2011

Article Tools

* Image Usage & Resolution